Results 141 to 150 of about 35,966 (245)

Design of a prodrug bispecific antibody masked by a functional molecule for lymphocyte activation for cancer therapy. [PDF]

J Biol Eng
Miura D, Kato Y, Yasunaga M, Kumagai I, Asano R.   +4 more
europepmc   +1 more source

Generation of lymphokine activated killer cells from CD 4-negative peripheral blood lymphocytes using the flask immobilized with anti-CD3 antibodies.

, 1994
Fumio Komatsu
openalex   +2 more sources

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. [PDF]

, 1982
Elizabeth A. Grimm, A Mazumder, H Z Zhang, Steven A. Rosenberg   +3 more
openalex   +1 more source

Mechanisms and clinical advancements of cell-based immunotherapies in non-small cell lung cancer: an integrated perspective. [PDF]

Front Immunol
Yang L, Gong Y.
europepmc   +1 more source

Retrospective analysis of sorafenib combined with interferon α-1b, interleukin-2, and thalidomide as maintenance therapy in FLT3-ITD-positive acute myeloid leukemia. [PDF]

Front Oncol
Cheng C, Mi R, Li D, Chen L, Wei X.
europepmc   +1 more source

Differential effects of age on chicken heterophil functional activation by recombinant chicken interleukin-2 [PDF]

, 2002
Kaiser, Pete, Kogut, Michael, Rothwell, Lisa   +2 more
core   +1 more source

ATIM-22. ADOPTIVE IMMUNOTHERAPY USING LYMPHOKINE-ACTIVATED αβ T-CELLS IMPROVES TEMOZOLOMIDE-INDUCED LYMPHOPENIA IN PATIENTS WITH GLIOMA [PDF]

, 2017
Yonehiro Kanemura, Miho Sumida, Yoshiko Okita, Ema Yoshioka, Atsuyo Yamamoto, Daisuke Kanematsu, Yukako Handa, Hayato Fukusumi, Yui Nozaki, Ai Takada, Masahiro Nonaka, Shin Nakajima, Kanji Mori, Shigenori Goto, Takashi Kamigaki, Tomoko Shofuda, Shusuke Moriuchi, Mami Yamasaki   +17 more
openalex   +1 more source

Prospects for Treatment of Lung Cancer Using Activated Lymphocytes Combined with Other Anti-Cancer Modalities. [PDF]

Adv Respir Med
Ganina A, Askarov M, Kozina L, Karimova M, Shayakhmetov Y, Mukhamedzhanova P, Brimova A, Berikbol D, Chuvakova E, Zaripova L, Baigenzhin A.   +10 more
europepmc   +1 more source

Donor pretreatment with FLT-3 ligand augments anti-donor CTL, NK and LAK cell activities within liver allografts and alters the pattern of intragraft apoptotic activity [PDF]

, 1998
Chambers, FG, Fu, F, Fung, JJ, Li, W, Lu, L, Pan, F, Qian, S, Starzl, TE, Steptoe, RJ, Thomson, AW   +9 more
core  

Transforming growth factor beta 1 (TGF-beta 1) produced in tumour tissue after chemotherapy acts as a lymphokine-activated killer attractant [PDF]

, 1996
Yasuhiro Kuramitsu, Manabu Nishibe, M Kobayashi, YUHJI TOGASHI, Lan Yuan, Makoto Takizawa, Futoshi Okada, Masashi Hosokawa   +7 more
openalex   +1 more source